#USA #Toronto #Life Sciences #Workflow Automation #ACTO AI

ACTO Launches ACTO AI Agents

In a groundbreaking move for the life sciences sector, ACTO has unveiled its new suite of AI agents, known as ACTO AI. Designed specifically to empower pharmaceutical, biotechnology, and medical companies, these intelligent agents aim to transform and streamline critical workflows within their platform. By integrating human intelligence with empathetic artificial intelligence, ACTO seeks to redefine how therapies reach patients after receiving regulatory approval.

The Need for Innovation

As the industry faces mounting pressure to deliver therapies and technologies faster, compounded by a growing shortage of skilled human resources, automation has become paramount. ACTO AI offers an intelligent solution that allows companies to maintain control while significantly improving efficiency and impact on the ground. The introduction of these AI workflow agents promises to alleviate the friction in processes that previously hindered productivity and effectiveness.

Key Features of ACTO AI

ACTO AI comprises 17 specialized agents designed to support key functions across the organization's workflows. These agents automate routine tasks that once required significant manual effort, heralding a new era of productivity in various areas, including:

• - Training Program Development: The agents streamline the creation of training courses, scenarios, role-playing simulations, quizzes, certifications, and comprehensive learning programs at an astonishing pace.
• - Certification Management: They enhance and standardize the certification process, ensuring consistent evaluation and scoring practices across the organization.
• - Content Governance: ACTO AI automates tedious asset management tasks, such as nomenclature cleanup, duplicate file identification, and content expiry date management, freeing up time for teams.
• - Coaching and Reporting: The automation extends to coaching report creation and review, ensuring timely feedback without administrative delays.
• - Information Retrieval: A natural language search layer enables users to quickly find vital content within the platform, enhancing overall efficiency.
• - Strategic Insights: The agents also provide a natural language layer over dashboards and field data, allowing leaders to speed up insights through conversational queries.

Inspired by Real Needs

Parth Khanna, CEO of ACTO, noted that the inspiration for these agents stemmed from the experiences shared by over 50,000 professionals using the ACTO platform daily. Through extensive conversations with clients and reviewing managerial feedback, ACTO identified workflows that consumed valuable time and slowed product launches, new employee onboarding, and field execution. This customer-centric development approach has led to the creation of ACTO AI workflow agents, aimed at eliminating friction and empowering clients beyond mere task management.

Transforming the Field Landscape

With 14 of the top 50 pharmaceutical companies, high-growth biotech firms, and leading medtech organizations already leveraging ACTO’s technology, the platform is set to significantly reshape field performance. ACTO’s commitment to combining human empathy with AI functionality allows for a deeper connection between sales professionals and their clients, thereby enriching customer engagement.

As ACTO continues to lead innovations, it seeks out partners committed to enhancing patient outcomes through efficient and impactful field operations. With ACTO AI, teams are better positioned to focus on what truly matters: nurturing relationships, exercising judgment, and strategic execution.

For more information or to request a demonstration, visit www.acto.com/AI. Follow ACTO on LinkedIn to stay updated on their latest news and breakthroughs in the life sciences arena.